Home » Topics » Regulatory » Patents

Patents
RSS

AC Immune identifies new MAPT aggregation inhibitors

Sep. 16, 2020

Bristol-Myers Squibb identifies TYK2 inhibitors

Sep. 16, 2020

C4 Therapeutics patents new CRBN-targeting compounds

Sep. 16, 2020

Bioardis divulges new FGFR4 inhibitors

Sep. 16, 2020

Novel IRE1 inhibitors identified by Genentech

Sep. 15, 2020

Praxis Biotech presents new ISR pathway inhibitors

Sep. 15, 2020

Cerepeut describes new quinazolinone compounds

Sep. 15, 2020

Newave Pharmaceutical divulges BTK inhibitors

Sep. 15, 2020

Lmito Therapeutics discloses NQO1 activators

Sep. 15, 2020

New antibacterials presented by Viridias

Sep. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...